{
    "nctId": "NCT05410951",
    "briefTitle": "LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients",
    "officialTitle": "LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Lobular Breast Carcinoma, Lobular in Situ Breast Carcinoma, BRCA1 Mutation, BRCA2 Mutation",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 800,
    "primaryOutcomeMeasure": "Relative frequency of patients with a germline mutation",
    "eligibilityCriteria": "Inclusion criteria:\n\n1. All LBC observed retrospectively at the European Institute of Oncology, with a proved diagnosis of LBC (biopsy or operated)\n2. Patients with blood available in biobank Exclusion criteria\n\n   * Patients with a previous cancer (except skin basal cell carcinoma)\n   * Patients with ductal or mixed BC",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}